In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1609-1611

  Deguchi, Takashi ^a   Kawamura, Takeshi ^a   Yasuda, Mitsuru ^a   Nakano, Masahiro ^a   Fukuda, Hideyuki ^b   Kato, Haru ^a   Kato, Naoki ^a   Okano, Yukio ^a   Kawada, Yukimichi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFAZOLIN; CEFIXIME; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG RESPONSE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

EID: 0030855858     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1609     Document Type: Article

References (16)

1. Breines, D. M., S. Ouabdessel, E. Y. Ng, J. Tankovic, S. Shah, C. J. Soussy, and D. Hooper. 1997. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob. Agents Chemother. 41:175-179.
2. Deguchi, T., A. Fukuoka, M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Nishino, S. Ishihara, Y. Ban, and Y. Kawada. 1997. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 41:699-701.
3. Gutmann, L., R. Williamson, N. Moreau, M.-D. Kitzis, E. Collatz, J. F. Acar, and F. Goldstein. 1985. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J. Infect. Dis. 151:501-507.
4. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.
5. Hirai, K. 1989. Quinolone-resistance mechanisms involved in outer membrane, p. 187-201. In P. B. Fernandes (ed.), International telesymposium on quinolones. J. R. Prous Science Publishers, Barcelona, Spain.
6. Hirai, K., H. Aoyama, T. Irikura, S. Iyobe, and S. Mitsubishi. 1986. Difference in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob. Agents Chemother. 29: 535-538.
7. Hirai, K., H. Aoyama, S. Suzue, T. Irikura, S. Iyobe, and S. Mitsubishi. 1986. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob. Agents Chemother. 30:248-253.
8. Hirai, K., M. Hosaka, Y. Niwata, T. Yasue, H. Fukuda, T. Ishizaki, S. Suzue, and K. Nishino. 1990. Antibacterial activity of AM-1155, a new quinolone, abstr. 385, p. 151. In Program and abstracts of the 30th Interscienee Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Kato, H., N. Kato, K. Watanabe, K. Ueno, H. Ushijima, S. Hashira, and T. Abe. 1994. Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit. J. Clin. Microbiol. 32:2067-2070.
10. Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
11. Kumagai, Y., J.-I. Kato, K. Hoshino, T. Akasaka, K. Sato, and H. Ikeda. 1996. Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene. Antimicrob. Agents Chemother. 40:710-714.
12. Sanders, C. C., W. E. Sanders, Jr., R. V. Goering, and V. Werner. 1984. Selection of multiple antibiotic resistance by quinolones, β-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob. Agents Chemother. 26:797-801.
13. Sawai, T., R. Hiruma, N. Kawana, M. Kaneko, F. Taniyasu, and A. Inami. 1982. Outer membrane permeation of β-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrob. Agents Chemother. 22:585-592.
14. Von Rosenstiel, N., and D. Adam. 1994. Quinolone antibacterials. An update of their pharmacology and therapeutic use. Drugs 47:872-901.
15. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
16. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.